Early and extensive CD55 loss from red blood cells supports a causal role in malarial anaemia
© Gwamaka et al; authors; licensee BioMed Central Ltd. 2011
Received: 27 June 2011
Accepted: 29 December 2011
Published: 29 December 2011
Levels of complement regulatory proteins (CrP) on the surface of red blood cells (RBC) decrease during severe malarial anaemia and as part of cell ageing process. It remains unclear whether CrP changes seen during malaria contribute to the development of anaemia, or result from an altered RBC age distribution due to suppressive effects of malaria on erythropoiesis.
A cross sectional study was conducted in the north-east coast of Tanzania to investigate whether the changes in glycosylphosphatidylinositol (GPI)-anchored complement regulatory proteins (CD55 and CD59) contributes to malaria anaemia. Blood samples were collected from a cohort of children under intensive surveillance for Plasmodium falciparum parasitaemia and illness. Levels of CD55 and CD59 were measured by flow cytometer and compared between anaemic (8.08 g/dl) and non- anaemic children (11.42 g/dl).
Levels of CD55 and CD59 decreased with increased RBC age. CD55 levels were lower in anaemic children and the difference was seen in RBC of all ages. Levels of CD59 were lower in anaemic children, but these differences were not significant. CD55, but not CD59, levels correlated positively with the level of haemoglobin in anaemic children.
The extent of CD55 loss from RBC of all ages early in the course of malarial anaemia and the correlation of CD55 with haemoglobin levels support the hypothesis that CD55 may play a causal role in this disorder.
Anaemia is a common devastating complication of malaria caused by Plasmodium falciparum. The pathogenesis of malarial anaemia is complex, multifactorial and incompletely understood. Direct destruction of infected red blood cells (RBC) during malaria seems to be a relatively minor contributing mechanism because parasite densities do not correspond to the severity of anaemia [1, 2]. As a result, malarial anaemia is considered to arise mainly from defective erythropoiesis or from removal of uninfected RBC .
Unusually low numbers of reticulocytes in the peripheral blood indicate ineffective erythropoiesis and are frequent in chronic malaria cases . During acute malaria, anaemia is thought to arise mainly from the loss of uninfected RBC [1, 2] although the mechanism for this is not completely understood. Uninfected RBC may be prematurely removed from the circulation by either phagocytic immune cells or complement attack. In Kenya, children with severe malarial anaemia demonstrated increased erythrophagocytosis as well as decreased levels of complement regulatory proteins (CrP) including complement receptor 1 (CR1) and decay accelerating factor (CD55) . Decreases in CrP levels may predispose RBC to destruction by complement activation, thus contributing to the development of anaemia. CrPs are absolutely required to protect RBC from spontaneous complement damage  and CrP deficiencies render RBC more susceptible to complement damage [6, 7].
Although levels of other surface molecules are known to vary as RBC age [8–11], changes in the CD55 and CD59 levels in relation to cell aging during malaria have not been examined. Impaired RBC production and shortened RBC survival occur during malaria, and together have the effect of reducing the production of new RBC and abbreviating the life span of old RBC . Thus, altered RBC age distributions might contribute to apparent changes in CrP levels during malarial anaemia. This study compared surface glycosylphosphatidylinositol (GPI)-anchored complement regulatory proteins levels on RBC of different ages in infected children with or without recent onset of malarial anaemia.
Study population and clinical procedures
Demographic characteristics of study groups
N = 21 (12/9)
N = 34 (16/18)
N = 50 (32/18)
Haemoglobin g/dl (SD)
The study population included children participating in a longitudinal birth cohort study managed by the Mother Offspring Malaria Studies (MOMS) Project. The study was based at Muheza Designated District Hospital (DDH), near the north-eastern coast of Tanzania, an area of intense malaria transmission.
Children participating in the birth cohort were examined by an assistant medical officer every two weeks during infancy and every month thereafter; each examination included blood smear analysis. Venous blood samples were collected at 3, 6 and 12 months of age, then once after every six months in the second and third years of life and during any episode of parasitaemia or illness. Children were treated for any malaria episode, and efficacy of treatment was confirmed one week later by repeat blood smear. Capillary blood was drawn into heparinized tubes for preparation of blood smears, and venous blood for blood cell counts was drawn into a syringe containing the anticoagulant Citrate/Phosphate/Dextrose. Parasites were detected by microscopic examination of Giemsa-stained thick and thin smears prepared from capillary or venous blood. Parasitaemia was quantified as the number of parasitized RBC per 200 white blood cells in the thick smear, and parasite species were determined by examination of the thin smear. Haemoglobin levels and other haematological parameters were determined by haematology analyzer Cell Dyne® 1200 (Abbott Diagnostics Division, IL, USA).
The analyses for this study involved 105 children aged between six and 30 months. Of these, 84 children were sequentially enrolled after being diagnosed as having malaria and 21 healthy children served as controls. Healthy control children were enrolled after being proved to have normal haemoglobin levels, free from P. falciparum infection both symptomatically and microscopic blood smear examination, and had no record of parasitaemia for at least three months prior to sampling. Clinical malaria was defined as asexual P. falciparum parasitaemia by blood smear coupled with symptoms suggestive of malaria, most commonly fever ≥ 37.5°C. Anaemia was defined as haemoglobin concentration below 10 g/dL. Children with sickle cell anaemia (HbSS), Glucose 6 phosphate dehydrogenase enzyme deficiency (both hemizygous males and homozygous female) and 3.7 kb deletion alpha-thalassemia (heterozygous and homozygous) were excluded from this analysis.
Women presenting at Muheza DDH for delivery were invited to enroll their offspring in the cohort, and provided signed consent prior to the participation of their newborns in the birth cohort study. Protocols for procedures used in this study were approved by the International Clinical Studies Review Committee of the Division of Microbiology and Infectious Diseases at the US National Institutes of Health, and ethical clearance was obtained from the Institutional Review Boards of Seattle Biomedical Research Institute and the National Institute for Medical Research in Tanzania.
Determination of RBC age profiles
RBC were separated into age subpopulations by a density gradient centrifugation method as described previously [12, 13] with minor modifications. RBC were separated from plasma and leukocytes by centrifugation at 600 × g for 5 minutes. After removing the plasma and leukocytes, RBC were washed in PBS buffer twice, and a 100 μl blood pellet was resuspended in RPMI 1640. Percoll (Sigma-Aldrich, St. Louis, MOUSA) density gradients were used to separate RBC into fractions of varying ages. Percoll/5% sorbitol (W/V) was prepared by dissolving 5 g of sorbitol in 10 ml RPMI 1640 then mixing with 90 ml of Percoll. This solution was diluted with RPMI 1640 to make 90%, 80%, 70%, 60% and 40% Percoll solutions, corresponding to the following densities 1.099 g/ml, 1.082 g/ml, 1.070 g/ml, 1.061 g/ml and 1.046 g/ml respectively. The gradients were prepared in 15 ml plastic tubes (1 ml of each fraction), with the highest Percoll concentration at the bottom. Thereafter, 0.1 ml packed RBC was diluted in 5 parts of RPMI 1640 then layered on top of the Percoll gradient, and centrifuged at 1075 × g for 20 minutes at room temperature. Each fraction of cells was aspirated and transferred to a new tube, washed twice in RPMI 1640, then suspended and pelleted by centrifugation at 600 × g for 5 minutes. The supernatant was removed, and the pelleted cells resuspended by adding 200 μl of RPMI 1640. The number of red cells in each fraction was counted by haematology analyzer, and the cells in each age group were calculated as proportions of the total number of cells.
Measurement of CD55 and CD59
Red blood cells were washed twice in PBS buffer supplemented with 1% BSA and 0.1% NaN3 then suspended in the same buffer at 1 × 106 cells/ml. To label CrP, the RBC were incubated with monoclonal antibodies against human CD55 and CD59, according to manufactures instructions (BD Biosciences-PharMingen, USA) conjugated to Cyanine 5 (CY5) and Phycoerythrin (PE), respectively. Irrelevant monoclonal antibodies of the same isotype were used as negative controls (Molecular Probes, USA). The samples were incubated at 4 C in the dark for 30 minutes. The RBC were washed twice in buffer, resuspended in PBS and analysed immediately by flow cytometer (Flomax, Partec, Germany). The cells were excited with 488 nm argon ion laser, and the logarithmic orange (PE) and red (CY 5) fluorescences were measured through FL2 and FL3 detectors respectively. RBC were gated on the basis of their logarithmic amplification of the light scatter properties. One thousand events were acquired in replicate for each sample. The results were presented as mean fluorescence intensity (MFI) of RBC with specific immunofluroescence above the background fluorescence as determined by isotype controls .
Detection of phosphatidylserine exposure
Annexin V-FITC apoptosis detection kit (Sigma-Aldrich) was used for the detection of phosphatidylserine on RBC surfaces. The cells were washed twice in PBS and then resuspend in 1 × binding buffer (100 mM HEPES/NaOH, pH 7.5 containing 1.4 M NaCl and 25 mM CaCl2) at a concentration of approximately1 × 106 cells/ml. Then 1 μl of Annexin V-FITC (Sigma) was added in each 100 μl of cell suspension and mixed thoroughly by gently vortex. The tubes were incubated at room temperature for exactly 10 minutes in the dark. Thereafter, 400 ml of binding buffer was added to each tube. Analysis by flow cytometer (Flomax - Partec® - Germany) was performed within 1 hr. The negative control was prepared each time by following all steps for PS staining except that the Annexin V-FITC addition step was skipped.
Validation of the Percoll density gradient method
Percoll density gradient method was validated by assessing the relationship between RBC density and age related modifications. Blood for this purpose was obtained from seven healthy donors, and then processed similar to other study subjects. After density gradient separation, each RBC fraction was analysed for the mean corpuscular volume (MCV), level of phosphatidylserine exposure to surface membranes and levels of CD55 and CD59.
Statistical analysis was performed using StatView version 5.0.1 (SAS Institute Inc. Cary, NC, USA) software package. The Mann-Whitney test was used to test differences between groups and Spearman rank correlation to examine relationships between variables. Multivariate linear regression analyses were used to determine the relationship between parasite density, CrP levels and child's age. A P value ≤ 0.05 was considered statistically significant.
Study population and characteristics
Demographic and laboratory characteristics of the study population are presented in Table 1.
RBC Age profiles
In most samples the cells separated into four distinct bands following centrifugation on Percoll density gradients and were designated as young for top band (60% Percoll solution), mature for second band from top (70% Percoll solution), old for third band form top (80% Percoll solution), and very old for the bottom band (90% Percoll solution) subsets . An additional layer containing mostly leukocytes, infected RBCs and few reticulocytes as assessed by microscopy was observed at the 40% Percoll solution layer in few samples, but this heterogeneous pool was not included in the current analysis.
Parameters used to validate the age-density relationship in RBC fractions separated by Percoll density gradient method
Erythrocyte Age Fraction
% of cells
Mean ± SD
Mean ± SD
Mean ± SD
Mean ± SD
23.5 ± 26.64
73.86 ± 1.29
1.36 ± 0.182
2.55 ± 0.512
3.39 ± 0.775
44.37 ± 18.53
73.43 ± 1.39
1.43 ± 0.088
2.11 ± 0.568
3.18 ± 0.692
25.86 ± 15.99
73.00 ± 1.41
1.56 ± 0.177
1.94 ± 0.617
3.02 ± 0.564
6.41 ± 7.94
72.29 ± 1.6
1.67 ± 0.23
1.89 ± 0.408
2.59 ± 0.475
Overall levels of CD55 but not CD59 were higher in the healthy controls than in other groups but this difference was only significant for the anaemic malaria cases. CD55 MFI levels were significantly higher in the healthy control group in all RBC subsets when compared to anaemic malaria cases i.e. median (IQR = 25-75%) for young [2.52 (0.36) versus 2.15(0.8), P = 0.0074]; mature [2.03 (0.46) versus 1.83 (0.44), P = 0.0026]; old [1.82 (0.47) versus 1.65 (0.33), P = 0.0327] and very old [1.67 (0.38) versus 1.69 (0.38), P = 0.0399] but not to the non-anaemic malaria cases i.e. median (IQR = 25-75%) for young [2.52 (0.36) versus 2.28(0.94), P = 0.2592]; mature [2.03 (0.46) versus 2.1(0.68), P = 0.4356]; old [1.82 (0.47) versus 1.87(0.34), P = 0.9791] and very old [1.67 (0.38) versus 1.75(0.29), P = 0.3080]. CD59 levels were low during malaria compared to normal controls but the differences were not significant for all RBC subsets.
CD55 levels correlated significantly with the level of haemoglobin in anaemic (Spearman rank test: young RBC, r = 0.506, P = 0.001; mature RBC, r = 0.421, P = 0.0063; old RBC, r = 0.526, P = 0.0008; very old RBC, r = 0.375, P = 0.0246) but not in non-anaemic children with malaria. CD59 level did not correlate with haemoglobin in either group of children.
CrP levels did not vary with child's age. CD55 but not CD59 levels were negatively associated with parasite density. The relationship of CD55 to parasite density was significant for both anaemic (r = -0.386; P = 0.0069) and non-anaemic populations (r = -0.469; P = 0.0063). Multivariate linear regression analyses for parasite density, CD55 levels and child's age as independent variables, and haemoglobin level as the dependent variable indicated that decreases in CD55 was associated with the odds (OR 95% CI) for low haemoglobin levels of 0.19 (0.05-0.83).
The results confirm previous findings that CD55 levels on the surface of RBC are lower in children with malarial anaemia , and in addition indicate that CD55 loss begins early in the course of disease and affects RBC of all ages. It is also shown that CD55 and CD59 levels decrease progressively as RBC age. Altered RBC age profiles during P. falciparum infections could therefore modify complement regulatory proteins (CrP) levels, but specifically do not account for the decrease in CrP during early malarial anaemia. The correlation between CD55 and haemoglobin levels in anaemic children suggests that CD55 loss may at least partially mediate the disease.
This study focused on acute episodes of mild to moderate anaemia. Children in the cohort were monitored intensively with routine blood smears, clinical examinations and prompt treatment in case of illness, and therefore chronic malaria cases were unlikely. Significant increase in number of young RBC in anaemic children suggests body's attempt to correct the reduction in cell mass resulting from malaria infection, and also suggests that these cases were acute and not chronic episodes . Earlier studies focused on hospitalized children with severe malarial anaemia and presumably many of these were chronic cases . Although CD55 levels were found to be higher in young RBC, the increase in the fraction of young RBC during malarial anaemia in this cohort did not lead to an overall increase of CD55 levels. RBC of all ages had lower CD55 levels in anaemic versus non-anaemic children, suggesting that an active process may be removing CD55 from RBC in cases of malarial anaemia.
Red blood cells were separated into fractions of different ages using Percoll density gradients method. Density gradient separation is a well validated technique which yields distinct cell populations with progressive shift in the cell age with density, and differ by physical and biochemical properties [15–17]. Decrease in the mean corpuscular volume, expression of GPI-anchored glycoproteins (CD55 and CD59) and increased exposure of phosphatidylserine (PS) on the external leaflet of cell membranes are related to the RBC aging process [10–18]. Indeed, in normal donor blood samples, there was a decrease in MCV, CD55 and CD59 inversely related to RBCs density. These observations, together with the increased exposure of phosphatidylserine (PS) in the more dense RBCs, supports the notion that in density -separated subsets, an enrichment of young, mature, old and very old RBCs subsets was attained.
Apparently, this is the first study to show variations in CD55 and CD59 levels in relation to RBC age during malaria. Earlier study reported a progressive decrease in CD55 and CD59 levels with RBC age in healthy donors [18, 19]. Reductions in CD55 and CD59 molecules during RBC aging in healthy individuals suggest that non-pathological mechanisms exist to mediate CrP loss throughout RBC life. These mechanisms are not fully understood, although several studies suggest that CrP molecules are lost from RBC through vesicle formation and extrusion from the cell surface [11–20]. Additional mechanisms may include proteolytic cleavage of CrP during transport and clearance of immune complexes from the RBC surface in the liver and spleen . However, the loss of RBC surface molecules during malarial anaemia appears to be a selective process. CD55 but not CD59 levels were significantly lower in anaemic donors. It is suggested that an active process separate from physiological cell ageing may be taking place during malaria that preferentially removes specific RBC surface molecules.
Alternatively the same mechanism responsible for physiological loss may be taking place, but at an accelerated rate for CD55. A process resembling transfer reaction of CR1 has been proposed to explain the loss of CD55 on RBC during malaria . During transfer reaction immune complexes are removed from RBC surfaces by phagocytes. In healthy individuals, RBC act as passive shuttles for the transport of complement-coated immune complexes from the circulation to the reticuloendothelial phagocytes in the liver and spleen.
The correlation between CD55 and haemoglobin as observed in this study suggests that CD55 depletion contribute to RBC loss during malarial anaemia. Erythrophagocytosis resulting from C3b deposition on RBC could explain the concomitant decrease of CD55 and haemoglobin. Severe malarial anaemia is associated with elevated levels of circulating immune complexes [22, 23], which could be adsorbed by CD55 and subsequently transferred to macrophages . The loss of CD55 during this process could compromise its regulatory function and allow the deposition of opsonin C3b on RBC [24, 25], leading to increased RBC destruction by the phagocytes in the reticuloendothelial tissues. Complement binding to RBC has been reported to be associated with macrophage activation and reduced haemoglobin in P. falciparum malaria .
Alternatively, direct lysis of RBC by membrane attack complex (MAC) could explain the concomitant decrease of CD55 and haemoglobin, but seems less likely. Children with severe malarial anaemia have been reported to have low levels of CR1 and CD55 . Such deficiencies would likely render the RBC vulnerable to complement attack, especially during complement activation which is common during malaria . However, CD59 did not decrease significantly during anaemia episodes in this or earlier studies , which imply that complement-mediated lysis is not the likely mechanism for RBC loss during malaria. CD59 is a principal regulatory protein of complement attack . Weisner et al found that despite the activation of all lytic complement factors, no complement-mediated lysis of RBC occurred in the presence of functional intrinsic CD59. Because CD59 levels do not change significantly during malarial anaemia, this probably limits complement-mediated lysis.
The differential loss of CD55 and CD59 may be related to their different roles in protection from complement attack. Activation of complement occurs in a step-wise fashion, and each regulatory protein acts at a different step in the cascade. CD55 acts at the initial enzymatic step to prevent the activation of C3 to C3b by accelerating the dissociation of the C3 convertase C4-2a and C3bBb [28–30]. CD59 prevents formation of polymeric C9 complex at the final step of MAC assembly . At least during acute malarial anaemia, CR1 and CD55 may sufficiently regulate the complement cascade to limit formation of MAC, thereby consuming CD55 and sparing CD59.
Demonstration of higher amounts of C3 activation and degradation fragments bound to the RBCs of the anaemic children and an inverse correlation with CD55 would be another approach to support the hypothesis that CD55 loss supports the causal role in malarial anaemia. Moreover, demonstration of C3b on the CD55 low cells, would argue that sublytic C5b-9 induced the ectocytosis of infected and bystander cells, which resulted in the preferential loss of CD55 over CD59. This phenomenon was not explored in the current study, but earlier studies by other researchers did demonstrate an increase in C3b deposition on low red cell CR1 and CD55 levels in children with severe malarial anaemia [24, 25].
Reductions in CD55 during malarial anaemia are evident in RBC of all ages, correlate with haemoglobin level, and develop early in the course of disease. Although the RBC age distribution changes during malarial anaemia, and CD55 levels decrease as RBC age, these changes do not account for the CD55 loss seen in children with new onset disease. Taken together, the results support the hypothesis that CD55 loss may play a causal role in malarial anaemia. It is suggested that the loss of CD55 during malaria compromises the complement regulatory function thereby allows the deposition of opsonin C3b on RBC leading to increased erythrophagocytosis and anaemia.
Conflict of interest
The authors declare that they have no competing interests.
The authors gratefully acknowledge the participation of the mothers and their children in the MOMS Project, and the work of the MOMS Project staff, including assistant medical officers, nurses, village health workers, laboratory technicians, microscopists, and data entry personnel. Also, the IHI core funding which paid for MG time while preparing this paper is acknowledged. This work was supported by funds to PED from the Grand Challenges in Global Health/Foundation for NIH Grant 1364, the National Institutes of Health Grant R01AI52059, and the Fogarty International Center (FIC)/NIH Grant D43 TW005509. This publication is solely the responsibility of the authors and does not necessarily represent the official views of the FIC.
- Jakeman GN, Saul A, Hogarth WL, Collins WE: Anemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected RBC. Parasitology. 1999, 119: 127-133. 10.1017/S0031182099004564.View ArticlePubMedGoogle Scholar
- Price RN, Simpson JA, Nosten F, Luxembuger C, Hkirjaroen L, ter Kuile F, Chongsuphajaisiddhi T, White NJ: Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg. 2001, 65: 614-622.PubMed CentralPubMedGoogle Scholar
- Wickramasinghe SN, Abdalla SH: Blood and bone marrow changes in malaria. Baillieres Best Pract Res Clin Haemato. 2000, 13: 277-99. 10.1053/beha.1999.0072.View ArticleGoogle Scholar
- Waitumbi JN, Opollo MO, Muga RO, Misore AO, Stoute JA: Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia. Blood. 2000, 95: 1481-1486.PubMedGoogle Scholar
- Molina H, Miwa T, Zhou L, Hilliard B, Mastellos D, Maldonado MA, Lambris JD, Song WC: Complement-mediated clearance of RBC: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor. Blood. 2002, 100: 4544-4549. 10.1182/blood-2002-06-1875.View ArticlePubMedGoogle Scholar
- Holt DS, Botto M, Bygrave AE, Hanna SM, Walport MJ, Morgan BP: Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood. 2001, 98: 442-449. 10.1182/blood.V98.2.442.View ArticlePubMedGoogle Scholar
- Miwa T, Maldonado MA, Zhou L, Sun X, Luo HY, Cai D, Werth VP, Madaio MP, Eisenberg RA, Song WC: Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Am J Pathol. 2002, 1: 1077-1086.View ArticleGoogle Scholar
- Ripoche J, Sim RB: Loss of complement receptor type 1 (CR1) on ageing of RBC. Studies of proteolytic release of the receptor. Biochem J. 1986, 235: 815-821.PubMed CentralView ArticlePubMedGoogle Scholar
- Fishelson Z, Marikovsky Y: Reduced CR1 expression on aged human RBC: immuno-electron microscopic and functional analysis. Mech Ageing Dev. 1993, 72: 25-35. 10.1016/0047-6374(93)90128-E.View ArticlePubMedGoogle Scholar
- Bratosin D, Mazurier J, Tissier JP, Estaquier J, Huart JJ, Ameisen JC, Aminoff D, Montreuil J: Cellular and molecular mechanisms of senescent RBC phagocytosis by macrophages. A review. Biochimie. 1998, 80: 173-195. 10.1016/S0300-9084(98)80024-2.View ArticlePubMedGoogle Scholar
- Miot S, Marfurt J, Lach-Trifilieff E, Gonzalez-Rubio C, Lopez-Trascasa M, Sadallah S, Schifferli JA: The mechanism of loss of CR1 during maturation of RBC is different between factor I deficient patients and healthy donors. Blood Cells Mol Dis. 2002, 29: 200-212. 10.1006/bcmd.2002.0559.View ArticlePubMedGoogle Scholar
- Rennie CM, Thompson S, Parker AC, Maddy A: Human erythrocyte fraction in "Percoll" density gradients. Clin Chim Acta. 1979, 98: 119-125. 10.1016/0009-8981(79)90172-4.View ArticlePubMedGoogle Scholar
- Omodeo-Salè F, Motti A, Basilico N, Parapini S, Olliaro P, Taramelli D: Accelerated senescence of human erythrocytes cultured with Plasmodium falciparum. Blood. 2003, 102: 705-711. 10.1182/blood-2002-08-2437.View ArticlePubMedGoogle Scholar
- Abdalla S, Weatherall DJ, Wickramasinghe SN, Hughes M: The anemia of P. falciparum malaria. Br J Haematol. 1980, 46: 171-183. 10.1111/j.1365-2141.1980.tb05956.x.View ArticlePubMedGoogle Scholar
- Mosca A, Paleari R, Modenese A, Rossini S, Parma R, Rocco C, Russo V, Caramenti G, Paderi ML, Galanello R: Clinical utility of fractionating erythrocytes into "Percll" density gradients. Adv Exp Med Biol. 1991, 307: 227-238.View ArticlePubMedGoogle Scholar
- Asano R, Murasugi E, Hokari S: Swine erythrocyte fractionation in Percoll density gradients. Zentralbl Veterinarmed A. 1993, 40: 641-645.View ArticlePubMedGoogle Scholar
- Romero PJ, Romero EA, Winkler MD: Ionic calcium content of light dense human red cells separated by Percoll density gradients. Biochim Biophys Acta. 1997, 1323: 23-28. 10.1016/S0005-2736(96)00141-1.View ArticlePubMedGoogle Scholar
- Risso A, Turello M, Biffoni F, Antonutto G: Red blood cell senescence and neocytolysis in humans after high altitude acclimatization. Blood Cells, Molecules, and Diseases. 2007, 38: 83-92. 10.1016/j.bcmd.2006.10.161.View ArticlePubMedGoogle Scholar
- Willekens FL, Werre JM, Groenen-Döpp YA, Roerdinkholder-Stoelwinder B, de Pauw B, Bosman GJ: Erythrocyte vesiculation: a self-protective mechanism?. Br J Haematol. 2008, 141: 549-556. 10.1111/j.1365-2141.2008.07055.x.View ArticlePubMedGoogle Scholar
- Dervillez X, Oudin S, Libyh MT, Tabary T, Reveil B, Philbert F, Bougy F, Pluot M, Cohen JH: Catabolism of the human RBC C3b/C4b receptor (CR1, CD35): Vesiculation and/or proteolysis?. Immunopharmacology. 1997, 38: 129-140. 10.1016/S0162-3109(97)00066-0.View ArticlePubMedGoogle Scholar
- Craig ML, Waitumbi JN, Taylor RP: Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1. J Immunol. 2005, 174: 3059-3066.View ArticlePubMedGoogle Scholar
- Mibei EK, Orago AS, Stoute JA: Immune complex levels in children with severe Plasmodium falciparum malaria. Am J Trop Med Hyg. 2005, 72: 593 599-PubMedGoogle Scholar
- Stoute JA, Odindo AO, Owuor BO, Mibei EK, Opollo MO, Waitumbi JN: Loss of red blood cell-complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia. J Infect Dis. 2003, 187: 522-5225. 10.1086/367712.View ArticlePubMedGoogle Scholar
- Owuor BO, Odhiambo CO, Otieno WO, Adhiambo C, Makawiti DW, Stoute JA: Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia. Mol Med. 2008, 14: 89-97.PubMed CentralView ArticlePubMedGoogle Scholar
- Odhiambo CO, Otieno W, Adhiambo C, Odera MM, Stoute JA: Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia. BMC Med. 2008, 6: 23-10.1186/1741-7015-6-23.PubMed CentralView ArticlePubMedGoogle Scholar
- Goka BQ, Kwarko H, Kurtzhals JA, Gyan B, Ofori-Adjei E, Ohene SA, Hviid L, Akanmori BD, Neequaye J: Complement binding to RBC is associated with macrophage activation and reduced haemoglobin in Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg. 2001, 95: 545-549. 10.1016/S0035-9203(01)90036-7.View ArticlePubMedGoogle Scholar
- Jhaveri KN, Ghosh K, Mohanty D, Parmar BD, Surati RR, Camoens HM, Joshi SH, Lyer YS, Desai A, Badakere SS: Autoantibodies, immunoglobulins, complement and circulating immune complexes in acute malaria. Natl Med J India. 1997, 10: 5-7.PubMedGoogle Scholar
- Wiesner J, Jomaa H, Wilhelm M, Tony HP, Kremsner PG, Horrocks P, Lanzer M: Host cell factor CD59 restricts complement lysis of Plasmodium falciparum-infected RBC. Eur J Immunol. 1997, 27: 2708-2713. 10.1002/eji.1830271034.View ArticlePubMedGoogle Scholar
- Kuttner-Kondo LA, Mitchell L, Houracade DE, Medof ME: Characterization of the active sites in decay-accelerating factor. J Immunol. 2001, 167: 2164-2171.View ArticlePubMedGoogle Scholar
- Nicholson-Weller A, Wang CE: Structure and function of decay accelerating factor CD55. J Lab Clin Med. 1994, 123: 485-491.PubMedGoogle Scholar
- Rollins SA, Zhao J, Ninomiwa H, Sims PJ: Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J Immunology. 1991, 146: 2345-2351.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.